{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2016:IIXM6GJXQXIXFB7UGCJACQHCL3","short_pith_number":"pith:IIXM6GJX","canonical_record":{"source":{"id":"1612.02705","kind":"arxiv","version":3},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2016-12-08T16:00:33Z","cross_cats_sorted":[],"title_canon_sha256":"1c716a0c641fa5b0b412344c6cf47561eb9101825865d6ac6c5ca3638857eb53","abstract_canon_sha256":"64dd14716fffd267742936fdeb617b8dfec7f65f966779205db6a3f23d82c57a"},"schema_version":"1.0"},"canonical_sha256":"422ecf193785d17287f430920140e25ee043e072d5ec59b4121071fbe04bbd9d","source":{"kind":"arxiv","id":"1612.02705","version":3},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1612.02705","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"arxiv_version","alias_value":"1612.02705v3","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1612.02705","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"pith_short_12","alias_value":"IIXM6GJXQXIX","created_at":"2026-05-18T12:30:22Z"},{"alias_kind":"pith_short_16","alias_value":"IIXM6GJXQXIXFB7U","created_at":"2026-05-18T12:30:22Z"},{"alias_kind":"pith_short_8","alias_value":"IIXM6GJX","created_at":"2026-05-18T12:30:22Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2016:IIXM6GJXQXIXFB7UGCJACQHCL3","target":"record","payload":{"canonical_record":{"source":{"id":"1612.02705","kind":"arxiv","version":3},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2016-12-08T16:00:33Z","cross_cats_sorted":[],"title_canon_sha256":"1c716a0c641fa5b0b412344c6cf47561eb9101825865d6ac6c5ca3638857eb53","abstract_canon_sha256":"64dd14716fffd267742936fdeb617b8dfec7f65f966779205db6a3f23d82c57a"},"schema_version":"1.0"},"canonical_sha256":"422ecf193785d17287f430920140e25ee043e072d5ec59b4121071fbe04bbd9d","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:18:27.018365Z","signature_b64":"yf4xLZaAsUKb26Cv+ZjXiXQeY4KpF6JS4a58QQzeNjfLJaK5JXnmvwIhe7pLlk/daB4s9CeYLNdmk7KSeIMKDg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"422ecf193785d17287f430920140e25ee043e072d5ec59b4121071fbe04bbd9d","last_reissued_at":"2026-05-18T00:18:27.017759Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:18:27.017759Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1612.02705","source_version":3,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:18:27Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"UwsX0H7kTBZ2QGPkW6E5quGnd7WQYVyXWV9WhkZPDLsBvWOHUQLfWl1he1LpZnXw0l4Rw+dPeID562lInoc3Ag==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T14:58:14.310881Z"},"content_sha256":"3561b60ced986f680237e885b670d2caee0c48c0c56c2b37235850477de3c859","schema_version":"1.0","event_id":"sha256:3561b60ced986f680237e885b670d2caee0c48c0c56c2b37235850477de3c859"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2016:IIXM6GJXQXIXFB7UGCJACQHCL3","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"A Nonparametric Bayesian Basket Trial Design","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Apostolia M Tsimberidou, Donald Berry, Peter Mueller, Yanxun Xu","submitted_at":"2016-12-08T16:00:33Z","abstract_excerpt":"Targeted therapies on the basis of genomic aberrations analysis of the tumor have shown promising results in cancer prognosis and treatment. Regardless of tumor type, trials that match patients to targeted therapies for their particular genomic aberrations have become a mainstream direction of therapeutic management of patients with cancer. Therefore, finding the subpopulation of patients who can most benefit from an aberration-specific targeted therapy across multiple cancer types is important. We propose an adaptive Bayesian clinical trial design for patient allocation and subpopulation iden"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1612.02705","kind":"arxiv","version":3},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:18:27Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"06y5Xt9xV4j9xc/H37Y3J6+JJIgel7wpwl0LN3NdfcICdSfYrYwKphWz3j+pIy6iy9h2LGVLuvNqkXRAAvG6CQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-26T14:58:14.311410Z"},"content_sha256":"b9d58ee2d53db29478ccc1e0f192128d9bb0c1d71f3815da074b8e523b892abe","schema_version":"1.0","event_id":"sha256:b9d58ee2d53db29478ccc1e0f192128d9bb0c1d71f3815da074b8e523b892abe"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/bundle.json","state_url":"https://pith.science/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-26T14:58:14Z","links":{"resolver":"https://pith.science/pith/IIXM6GJXQXIXFB7UGCJACQHCL3","bundle":"https://pith.science/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/bundle.json","state":"https://pith.science/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/state.json","well_known_bundle":"https://pith.science/.well-known/pith/IIXM6GJXQXIXFB7UGCJACQHCL3/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2016:IIXM6GJXQXIXFB7UGCJACQHCL3","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"64dd14716fffd267742936fdeb617b8dfec7f65f966779205db6a3f23d82c57a","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2016-12-08T16:00:33Z","title_canon_sha256":"1c716a0c641fa5b0b412344c6cf47561eb9101825865d6ac6c5ca3638857eb53"},"schema_version":"1.0","source":{"id":"1612.02705","kind":"arxiv","version":3}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1612.02705","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"arxiv_version","alias_value":"1612.02705v3","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1612.02705","created_at":"2026-05-18T00:18:27Z"},{"alias_kind":"pith_short_12","alias_value":"IIXM6GJXQXIX","created_at":"2026-05-18T12:30:22Z"},{"alias_kind":"pith_short_16","alias_value":"IIXM6GJXQXIXFB7U","created_at":"2026-05-18T12:30:22Z"},{"alias_kind":"pith_short_8","alias_value":"IIXM6GJX","created_at":"2026-05-18T12:30:22Z"}],"graph_snapshots":[{"event_id":"sha256:b9d58ee2d53db29478ccc1e0f192128d9bb0c1d71f3815da074b8e523b892abe","target":"graph","created_at":"2026-05-18T00:18:27Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Targeted therapies on the basis of genomic aberrations analysis of the tumor have shown promising results in cancer prognosis and treatment. Regardless of tumor type, trials that match patients to targeted therapies for their particular genomic aberrations have become a mainstream direction of therapeutic management of patients with cancer. Therefore, finding the subpopulation of patients who can most benefit from an aberration-specific targeted therapy across multiple cancer types is important. We propose an adaptive Bayesian clinical trial design for patient allocation and subpopulation iden","authors_text":"Apostolia M Tsimberidou, Donald Berry, Peter Mueller, Yanxun Xu","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2016-12-08T16:00:33Z","title":"A Nonparametric Bayesian Basket Trial Design"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1612.02705","kind":"arxiv","version":3},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:3561b60ced986f680237e885b670d2caee0c48c0c56c2b37235850477de3c859","target":"record","created_at":"2026-05-18T00:18:27Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"64dd14716fffd267742936fdeb617b8dfec7f65f966779205db6a3f23d82c57a","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2016-12-08T16:00:33Z","title_canon_sha256":"1c716a0c641fa5b0b412344c6cf47561eb9101825865d6ac6c5ca3638857eb53"},"schema_version":"1.0","source":{"id":"1612.02705","kind":"arxiv","version":3}},"canonical_sha256":"422ecf193785d17287f430920140e25ee043e072d5ec59b4121071fbe04bbd9d","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"422ecf193785d17287f430920140e25ee043e072d5ec59b4121071fbe04bbd9d","first_computed_at":"2026-05-18T00:18:27.017759Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:18:27.017759Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"yf4xLZaAsUKb26Cv+ZjXiXQeY4KpF6JS4a58QQzeNjfLJaK5JXnmvwIhe7pLlk/daB4s9CeYLNdmk7KSeIMKDg==","signature_status":"signed_v1","signed_at":"2026-05-18T00:18:27.018365Z","signed_message":"canonical_sha256_bytes"},"source_id":"1612.02705","source_kind":"arxiv","source_version":3}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:3561b60ced986f680237e885b670d2caee0c48c0c56c2b37235850477de3c859","sha256:b9d58ee2d53db29478ccc1e0f192128d9bb0c1d71f3815da074b8e523b892abe"],"state_sha256":"c51eb3fed08b64e0e7a70864ac906a582806c916fca3b60e9f3b9f6f149a27e3"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"F3YCbDRfV4oVdCrm16L3ZFX5FcuuACTIZsnUyS3MkgE+PTRgpMEub9BljXMVqgB7uafMZGUV5nnyj7PCL2/AAA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-26T14:58:14.314905Z","bundle_sha256":"b34803949b23785e916759364ace4510bd94567df0d1591c130b093be8884d00"}}